Evidence map›Paper›PMID 32354631›Full record

ArticleDiagnostic and interventional imaging2020

3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic.

M Sapoval, A L Gaultier, C Del Giudice, O Pellerin, N Kassis-Chikhani, V Lemarteleur, V Fouquet, L Tapie, P Morenton, B Tavitian and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Diagnostic and interventional imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Imaging of COVID-19: An update of current evidences.Diagnostic and interventional imaging · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  12. Review on 3D printing: Fight against COVID-19.Materials chemistry and physics · 2021
    Article
  13. Article
  14. How chemical engineers can contribute to fight the COVID-19.Journal of the Taiwan Institute of Chemical Engineers · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M SapovalUniversité de Paris, PARCC, Inserm, 75015 Paris, France; Department of Vascular and Oncological Interventional Radiology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France. Electronic address: marc.sapoval2@aphp.fr.
A L GaultierUniversité de Paris, PARCC, Inserm, 75015 Paris, France; Department of Radiology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
C Del GiudiceUniversité de Paris, PARCC, Inserm, 75015 Paris, France; Department of Vascular and Oncological Interventional Radiology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
O PellerinUniversité de Paris, PARCC, Inserm, 75015 Paris, France; Department of Vascular and Oncological Interventional Radiology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
N Kassis-ChikhaniMedical Hygien Department, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
V LemarteleurUniversité de Paris, Centre de Simulation Ilumens, 75006 Paris, France.
V FouquetUnité de Recherches Biomatériaux Innovants et Interfaces (URB2i - EA 4462), Université de Paris, Paris, France; Hopital Louis-Mourier, 92700 Colombes, France.
L TapieUnité de Recherches Biomatériaux Innovants et Interfaces (URB2i - EA 4462), Université Sorbonne Paris Nord, 93430 Villetaneuse, France.
P MorentonCentraleSupelec, Université Paris-Saclay, 91192 Gif-sur-Yvette, France.
B TavitianUniversité de Paris, PARCC, Inserm, 75015 Paris, France; Department of Radiology, AP-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France.
J P AttalUnité de Recherches Biomatériaux Innovants et Interfaces (URB2i - EA 4462), Université de Paris, Hôpital Charles Foix, 94200 Ivry-sur-Seine, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to report the clinical evaluation of a 3D-printed protective face shield designed to protect interventional radiologists from droplet transmission of the SARS-Cov-2. MATERIALS AND

methodsA protective face shield consisting in a standard transparent polymerizing vinyl chloride (PVC) sheet was built using commercially available 3D printers. The 3D-printed face shield was evaluated in 31 interventional procedures in terms of ability to perform the assigned intervention as usual, quality of visual comfort and tolerance using a Likert scale (from 1, as very good to 5, as extremely poor).

resultsThe mean rating for ability to perform the assigned intervention as usual was 1.7±0.8 (SD) (range: 1-4). The mean visual tolerance rating was 1.6±0.7 (SD) (range: 1-4). The mean tolerability rating was 1.4±0.7 (SD) (range: 1-3).

conclusionThe 3D-printed protective face shield is well accepted in various interventions. It may become an additional option for protection of interventional radiologists.

Indexed as

BetacoronavirusMasksPrinting, Three-DimensionalCoronavirus InfectionsCOVID-19Equipment DesignEquipment ReuseHumansPandemicsPneumonia, ViralProspective StudiesRadiography, InterventionalSARS-CoV-2Time FactorsCOVID-19Interventional radiologyProtective face shieldThree-dimensional printing

Identifiers

PMID32354631
PMCPMC7166022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.